Amplification of overlapping DNA amplicons in a single-tube multiplex PCR for targeted next-generation sequencing of BRCA1 and BRCA2

被引:19
|
作者
Schenk, Desiree [1 ]
Song, Gang [1 ]
Ke, Yue [1 ]
Wang, Zhaohui [1 ]
机构
[1] Pillar Biosci, Dept Res & Dev, Natick, MA 01760 USA
来源
PLOS ONE | 2017年 / 12卷 / 07期
关键词
HYBRIDIZATION; ENRICHMENT; CAPTURE;
D O I
10.1371/journal.pone.0181062
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Current PCR-based target enrichment methods for next generation sequencing (NGS) of overlapping amplicons often requires separate PCR reactions and subsequent pooling of amplicons from the different reactions. The study presents a novel method, deemed stemloop inhibition mediated amplification (SLIMamp), for amplifying overlapping or tiled amplicons in a single multiplex PCR reaction. During a SLIMamp PCR reaction, a stem loop structure formed by the overlapping amplicon suppresses additional amplification of itself by preventing the annealing of the primers. Using the SLIMamp strategy, we designed a nextgeneration sequencing (NGS) assay to enrich the exon regions of BRCA1 and BRCA2 for sequencing on an Illumina MiSeq system. We used 35 cell line DNAs and 6 patient blood DNAs in the study to evaluate the assay performance. For each sample, all targeted regions were successfully amplified and sequenced with excellent coverage uniformity and specificity. >99% of the total sequencing reads were mapped to the human reference genome (hg19) and >99% of the mapped reads were on the targeted exons. >98% of bases were covered at >0.20x of the mean coverage and >99% are covered at >0.15x of the mean depth. Among 34 independently sequenced samples, all variants were reliably detected with no false positives or false negatives. SLIMamp provides a robust method for singletube multiplex PCR amplification of numerous, overlapping amplicons that tile for targeted next-generation sequencing.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] Comparison of Targeted Next-Generation and Sanger Sequencing for the BRCA1 and BRCA2 Mutation Screening
    Park, Joonhong
    Jang, Woori
    Chae, Hyojin
    Kim, Yonggoo
    Chi, Hyun Young
    Kim, Myungshin
    [J]. ANNALS OF LABORATORY MEDICINE, 2016, 36 (02) : 197 - 201
  • [2] Long-Range PCR and Next-Generation Sequencing of BRCA1 and BRCA2 in Breast Cancer
    Ozcelik, Hilmi
    Shi, Xuejiang
    Chang, Martin C.
    Tram, Eric
    Vlasschaert, Matt
    Di Nicola, Nando
    Kiselova, Anna
    Yee, Denise
    Goldman, Aaron
    Dowar, Mark
    Sukhu, Balram
    Kandel, Rita
    Siminovitch, Kathy
    [J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2012, 14 (05): : 467 - 475
  • [3] Evaluation of a Next-Generation Sequencing Assay for BRCA1 and BRCA2 Mutation Detection
    Capone, Gabriele Lorenzo
    Putignano, Anna Laura
    Saavedra, Sharon Trujillo
    Paganini, Irene
    Sestini, Roberta
    Gensini, Francesca
    De Rienzo, Irene
    Papi, Laura
    Porfirio, Berardino
    [J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2018, 20 (01): : 87 - 94
  • [4] Next-generation sequencing of BRCA1 and BRCA2 in breast cancer patients and control subjects
    Balabanski, Lubomir
    Antov, Georgi
    Dimova, Ivanka
    Ivanov, Samuil
    Nacheva, Maria
    Gavrilov, Ivan
    Nesheva, Desislava
    Rukova, Blaga
    Hadjidekova, Savina
    Malinov, Maxim
    Toncheva, Draga
    [J]. MOLECULAR AND CLINICAL ONCOLOGY, 2014, 2 (03) : 435 - 439
  • [5] The molecular analysis of BRCA1 and BRCA2: Next-generation sequencing supersedes conventional approaches
    D'Argenio, Valeria
    Esposito, Maria Valeria
    Telese, Antonella
    Precone, Vincenza
    Starnone, Flavio
    Nunziato, Marcella
    Cantiello, Piergiuseppe
    Iorio, Mariangela
    Evangelista, Eloisa
    D'Aiuto, Massimiliano
    Calabrese, Alessandra
    Frisso, Giulia
    D'Aiuto, Giuseppe
    Salvatore, Francesco
    [J]. CLINICA CHIMICA ACTA, 2015, 446 : 221 - 225
  • [6] Multiplex PCR heteroduplex analysis of BRCA1 and BRCA2
    Schofield, A
    Haites, NE
    [J]. JOURNAL OF MEDICAL GENETICS, 1999, 36 : S87 - S87
  • [7] Comprehensive Detection of BRCA1/2 Pathogenic Variants by Anchored Multiplex PCR and Next-Generation Sequencing
    Garnett, A. T.
    Hoskins, L. J.
    Moore, K. E.
    Griffin, L. M.
    Walters, R. D.
    [J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2017, 19 (06): : 1042 - 1043
  • [8] A reliable method for the detection of BRCA1 and BRCA2 mutations in fixed tumour tissue utilising multiplex PCR-based targeted next generation sequencing
    Ellison, Gillian
    Huang, Shuwen
    Carr, Hedley
    Wallace, Andrew
    Ahdesmaki, Miika
    Bhaskar, Sanjeev
    Mills, John
    [J]. BMC CLINICAL PATHOLOGY, 2015, 15
  • [9] Development and Validation of a Next-Generation Sequencing Assay for BRCA1 and BRCA2 Variants for the Clinical Laboratory
    Strom, Charles M.
    Rivera, Steven
    Elzinga, Christopher
    Angeloni, Taraneh
    Rosenthal, Sun Hee
    Goos-Root, Dana
    Siaw, Martin
    Platt, Jamie
    Braastadt, Cory
    Cheng, Linda
    Ross, David
    Sun, Weimin
    [J]. PLOS ONE, 2015, 10 (08):
  • [10] Detection of BRCA1 and BRCA2 germline mutations in Japanese population using next-generation sequencing
    Hirotsu, Yosuke
    Nakagomi, Hiroshi
    Sakamoto, Ikuko
    Amemiya, Kenji
    Mochizuki, Hitoshi
    Omata, Masao
    [J]. MOLECULAR GENETICS & GENOMIC MEDICINE, 2015, 3 (02): : 121 - 129